Moderna Targets 2021 Back-To-School Season For Pediatric Data On COVID-19 Vaccine

 
• By Derrick Gingery

Sponsors are moving to younger populations as the adult clinical trials near enrollment goals; Moderna’s CEO says data in children younger than 12 will be slow to emerge.

Child with face mask getting vaccinated
The FDA said the expanded access pathway will not be used to make a vaccine available for children unless safety and immunogenicity data in that group is available. • Source: Shutterstock

More from Vaccines

More from Pink Sheet